Scribd
Upload
12K views1 page

Blood Cancer

Uploaded by

dipak923434
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
12K views1 page

Blood Cancer

Uploaded by

dipak923434
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

000058755460

BLOOD CANCER OXR – FINAL REPORTOncoBREAST Dx

Patient Information

Identification Data General Biochemistry Blood Drawn Realization


HRN: BRE0027555273 Creatinine (mg/dL): 1.00 Blood Drawn Date: 22-06-2024
Name: Mohan Kumar ASAT (U/L): 8.00
ALAT (U/L): 12.00 Urine Tumor Markers
Personal Data GGT (U/L): 7.00 8-OHdG (ng/mL): 11.10
Age (years): 23 Total Bilirubin (mg/dL): 1.00
Hemolized Sample: No Urine Drawn Realization
Comorbidities Urine Drawn Date: 22-06-2024
Atherosclerosis: No Serum Tumor Markers
Chronic Liver Disease: Yes CA 15.3 (U/mL): 19.70 Lifestyle
Diabetes Mellitus 1 or 2: No CEA (ng/mL): 1.60 Smoking: Negative
Jaundice: No EGFR (ng/mL): 5.00
Renal Failure: Yes NGAL (ng/mL): 4.60
NSE (ng/mL): 7.00

Outcome

Results
Some Tumor Markers are outside the reference range and suggest malignancy.

“High”
Range: Low, Moderate, High

Comments
In absence of comorbidities that are well-known source of False Positive (FP) in healthy patients by
increasing some Tumor Markers levels, whole Tumor Markers levels suggest malignancy.

Conclusions
WE SUGGEST BLOOD CANCER. THE 2016 ICD-10-CM DIAGNOSIS CODE IS C50 (MALIGNANT
NEOPLASM OF BLOOD).

This report has been generated from the data entered on 25-06-2024 10:55:02 UTC/GMT.

Disclaimer
This Multiple Biomarkers Disease Activity Algorithm (MBDAA) for Blood Cancer has been developed for the
exclusive use by healthcare professionals, and solely as a Clinical Decision Support System (CDSS), not
as an unique element for diagnosis. The algorithm bears a Sensitivity = 82.3%, Specificity = 85.7%. Please
note, negativity of the Tumor Markers does not exclude at 100% the possibility of a malignant epithelial
tumor.

Christian Medical College, Technical Responsible


Vellore Lorena Lendinez
Email: info@cmcvellore.com Chief Scientific Officer
Website: www.friendsoftheroyallondonhospital.org.uk The Royal London Hospital

Powered by TCPDF (www.tcpdf.org)

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy